The largest database of trusted experimental protocols

Polyclonal secondary antibody

Manufactured by Agilent Technologies
Sourced in Belgium

Polyclonal secondary antibodies are laboratory reagents used to detect and quantify target proteins in various experimental techniques, such as Western blotting, immunohistochemistry, and ELISA. They are produced by immunizing animals with a specific antigen, resulting in the generation of a diverse population of antibodies that recognize multiple epitopes on the target protein.

Automatically generated - may contain errors

2 protocols using polyclonal secondary antibody

1

Bone Marrow Cell Signaling Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow from naïve mice was collected as described above. 1×106 cells were cultured in a 12-well flat-bottom plate and incubated for three days in RPMI containing 10% serum. Supernatant with non-adherent cells was removed. After 4h incubation (which was optimal for mTOR phosphorylation) with or without 5 μg/mL β-glucan ± 100 ng/mL IL-38 in RPMI, cells were lysed in RIPA buffer containing Protease Inhibitor (Roche). Total protein content was determined by BCA assay (Thermo Fisher Scientific) and equal amounts of proteins were subjected to SDS-PAGE on pre-casted 4–15% gels (Biorad, CA, USA). The separated proteins were transferred to a nitrocellulose membrane (Biorad), which was blocked in 5% BSA (Sigma) and incubated overnight at 4oC with rabbit polyclonal antibodies against (phospho) mTOR, Akt, 4EBP1, and S6K (Cell Signaling, Danvers, MA, USA), and β-actin (Sigma), which were visualized using a polyclonal secondary antibody (Dako, Belgium) and SuperSignal West Femto Substrate (Thermo Fisher Scientific) for the phosphorylated proteins or ECL substrate for the other proteins (Biorad).
+ Open protocol
+ Expand
2

Activation of mTOR Signaling by β-Glucan

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow from naïve mice was collected as described earlier. A total of 1 × 106 cells were cultured in a 12‐well flat‐bottom plate and incubated for 3 d in RPMI containing 10% serum. Supernatant with nonadherent cells was removed. After 4 h incubation (which was optimal for mTOR phosphorylation) with or without 5 μg/ml β‐glucan ± 100 ng/ml IL‐38 in RPMI, cells were lysed in RIPA buffer containing protease inhibitor (Roche, Basel, Switzerland). Total protein content was determined by BCA assay (Thermo Fisher Scientific), and equal amounts of proteins were subjected to SDS‐PAGE on precasted 4–15% gels (Biorad, Hercules, CA, USA). The separated proteins were transferred to a nitrocellulose membrane (Biorad), which was blocked in 5% BSA (Sigma) and incubated overnight at 4°C with rabbit polyclonal antibodies against (phospho) mTOR, Akt, 4EBP1, and S6K (Cell Signaling, Danvers, MA, USA), and β‐actin (Sigma), which were visualized using a polyclonal secondary antibody (Dako, Leuven, Belgium) and SuperSignal West Femto Substrate (Thermo Fisher Scientific) for the phosphorylated proteins or ECL substrate for the other proteins (Biorad).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!